Jamison David E, Cohen Steven P
Department of Anesthesiology, Walter Reed National Military Medical Center (WRNMMC), Bethesda, MD, USA,
Department of Anesthesiology, Uniformed Services University of Health Sciences (USUHS), Bethesda, MD, USA,
J Pain Res. 2018 Sep 18;11:1879-1888. doi: 10.2147/JPR.S144633. eCollection 2018.
The use of radiofrequency ablation (RFA) procedures to treat chronic knee pain has surged in the past decade, though many questions remain regarding anatomical targets, selection criteria, and evidence for effectiveness.
A comprehensive literature review was performed on anatomy, selection criteria, technical parameters, results of clinical studies, and complications. Databases searched included MEDLINE and Google Scholar, with all types of clinical and preclinical studies considered.
We identified nine relevant clinical trials, which included 592 patients, evaluating knee RFA for osteoarthritis and persistent postsurgical pain. These included one randomized, placebo-controlled trial, one randomized controlled trial evaluating RFA as add-on therapy, four comparative-effectiveness studies, two randomized trials comparing different techniques and treatment paradigms, and one non-randomized, controlled trial. The results of these studies demonstrate significant benefit for both reduction and functional improvement lasting between 3 and 12 months, with questionable utility for prognostic blocks. There was considerable variation in the described neuroanatomy, neural targets, radiofrequency technique, and selection criteria.
RFA of the knee appears to be a viable and effective treatment option, providing significant benefit to well-selected patients lasting at least 3 months. More research is needed to better identify neural targets, refine selection criteria to include the use of prognostic blocks, optimize treatment parameters, and better elucidate relative effectiveness compared to other treatments.
在过去十年中,使用射频消融(RFA)程序治疗慢性膝关节疼痛的情况激增,尽管在解剖学靶点、选择标准和有效性证据方面仍存在许多问题。
对解剖学、选择标准、技术参数、临床研究结果和并发症进行了全面的文献综述。检索的数据库包括MEDLINE和谷歌学术,纳入了所有类型的临床和临床前研究。
我们确定了9项相关临床试验,共纳入592例患者,评估膝关节RFA治疗骨关节炎和术后持续性疼痛的效果。这些试验包括1项随机、安慰剂对照试验,1项评估RFA作为辅助治疗的随机对照试验,4项比较有效性研究,2项比较不同技术和治疗模式的随机试验,以及1项非随机对照试验。这些研究结果表明,RFA在减轻疼痛和功能改善方面具有显著益处,持续时间为3至12个月,而预后阻滞的效用存疑。在描述的神经解剖学、神经靶点、射频技术和选择标准方面存在相当大的差异。
膝关节RFA似乎是一种可行且有效的治疗选择,能为精心挑选的患者提供至少持续3个月的显著益处。需要更多研究来更好地确定神经靶点,完善选择标准以纳入预后阻滞的应用,优化治疗参数,并更好地阐明与其他治疗相比的相对有效性。